Using plasma membrane repair mechanisms to enhance neuronal resilience in neurodegenerative diseases
plasma membrane repair
neurodegeneration
lipid bilayer
neuroprotection
cell therapy
Mitigating neuroinflammation through inflammasome inhibition in neurodegenerative diseases
neuroinflammation
inflammasome
neurodegenerative diseases
therapeutic targets
CNS disorders
Exploring the role of gut microbiome ecosystems in neurodegenerative disease progression
microbiome
neurodegeneration
neuroinflammation
alpha-synuclein
microbial metabolites
Targeting prion disease reversal through engineered CRISPR-Cas13 systems
prion disease
CRISPR-Cas13
neurodegenerative therapy
protein misfolding
RNA editing
Targeting prion disease reversal via CRISPR-Cas13 RNA editing
prion therapeutics
RNA interference
neurodegenerative diseases
CRISPR-Cas13
protein misfolding
Targeting prion disease reversal with CRISPR-based gene therapy approaches
prion disease
CRISPR
gene therapy
neurodegeneration
protein misfolding
Targeting cellular senescence via CRISPR-based gene editing in age-related disease models
cellular senescence
CRISPR
age-related diseases
gene editing
neurodegeneration
Through proteostasis network modulation: targeting neurodegenerative protein aggregation
proteostasis
neurodegeneration
protein aggregation
Alzheimer’s
Parkinson’s
Targeting protein misfolding through proteostasis network modulation in neurodegenerative diseases
protein misfolding
proteostasis network
neurodegenerative diseases
aggregation
therapeutic intervention
In viral vector engineering for targeted gene delivery to neural tissues
gene therapy
neurotropic viruses
blood-brain barrier
CRISPR delivery
neurodegenerative diseases
Targeting prion disease reversal through proteostasis network modulation
prions
protein misfolding
chaperone proteins
neurodegeneration
therapeutic targets
Using plasma membrane repair mechanisms to treat neurodegenerative diseases
plasma membrane repair
neurodegeneration
cellular therapy
Alzheimer's
neuroprotection